Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
First Edition BOGP (0)
Royaume-Uni (3)
Advocacy (policy advocacy, lobbying)
Pharmaceutical Company (9)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Capacity and capabilities for engagement
Clinical study phase II